Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001209191-23-051695

Options or other derivatives

  • Chief Executive Officer acquired 522,558 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lennon David James · Chief Executive Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-10-02 Grant or award : show line 1 in the form Restricted Stock Units +32,558 32,558 D
2023-10-02 Grant or award : show line 2 in the form Stock Option (right to buy) +490,000 490,000 D
Loading xslF345X05/doc4.xml…